Skip to content

The efficacy and safety of single port laparoscopic myomectomy of uterus without catheterization in daysurgery under enhanced recovery mode: a single blind randomized controlled trial

The efficacy and safety of single port laparoscopic myomectomy of uterus without catheterization in daysurgery under enhanced recovery mode: a single blind randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042361
Enrollment
Unknown
Registered
2021-01-21
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases of obstetrics and gynecolog

Interventions

Sponsors

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged between 18-65 years; 2) Hysteromyoma >= 4cm, patients with fertility requirements, hysteromyoma >= 5cm, hysteromyoma degeneration, anemia caused by hysteromyoma, etc; 3) Have a certain degree of education and good reading comprehension ability; 4) American Society of anesthesiologists (a) grade 1-11; 5) Patients can understand the protocol and are willing to participate in the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1) There are medical complications (such as: hypertension, diabetes, heart disease, kidney disease, etc. and the condition is not effectively controlled); 2) Body temperature > 37.5 degrees C; HB < 80g / L; 3) There is a history of multiple pelvic and abdominal surgery, pelvic adhesion is serious; 4) There are recent gastrointestinal diseases, central nervous system diseases that can cause nausea and vomiting, cochlear diseases, etc.; 5) There are recent complications Patients with urinary tract symptoms or infection; 6) Participated in other clinical trials within three months before participating in this experiment; 7) Had mental illness or drug abuse that may affect compliance with the requirements of this experiment; 8) Other researchers considered that they were not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Incidence of urinary tract irritation;

Secondary

MeasureTime frame
Urinary tract infection rate;Urinary retention rate;First time out of bed;First exhaust time;Postoperative comfort score;Satisfaction;

Countries

China

Contacts

Public ContactYujian Jia

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China

236640366@qq.com+86 13094429439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026